CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.
CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.
复制标题
DOI:
10.1016/j.jcmg.2013.05.013
复制
发表时间:
2013-09
影响因子:
14
通讯作者:
Kwong, Raymond Y.
中科院分区:
文献类型:
--
作者:
Neilan, Tomas G.;Coelho-Filho, Otavio R.;Danik, Stephan B.;Shah, Ravi V.;Dodson, John A.;Verdini, Daniel J.;Tokuda, Michifumi;Daly, Caroline A.;Tedrow, Usha B.;Stevenson, William G.;Jerosch-Herold, Michael;Ghoshhajra, Brian B.;Kwong, Raymond Y.
关键词:
This study sought to determine whether the extent of late gadolinium enhancement (LGE) can provide additive prognostic information in patients with a nonischemic dilated cardiomyopathy (NIDC) with an indication for implantable cardioverter-defibrillator (ICD) therapy for the primary prevention of sudden cardiac death (SCD). Data suggest that the presence of LGE is a strong discriminator of events in patients with NIDC. Limited data exist on the role of LGE quantification. The extent of LGE and clinical follow-up were assessed in 162 patients with NIDC prior to ICD insertion for primary prevention of SCD. LGE extent was quantified using both the standard deviation–based (2-SD) method and the full-width half-maximum (FWHM) method. We studied 162 patients with NIDC (65% male; mean age: 55 years; left ventricular ejection fraction [LVEF]: 26 ± 8%) and followed up for major adverse cardiac events (MACE), including cardiovascular death and appropriate ICD therapy, for a mean of 29 ± 18 months. Annual MACE rates were substantially higher in patients with LGE (24%) than in those without LGE (2%). By univariate association, the presence and the extent of LGE demonstrated the strongest associations with MACE (LGE presence, hazard ratio [HR]: 14.5 [95% confidence interval (CI): 6.1 to 32.6; p < 0.001]; LGE extent, HR: 1.15 per 1% increase in volume of LGE [95% CI: 1.12 to 1.18; p < 0.0001]). Multivariate analyses showed that LGE extent was the strongest predictor in the best overall model for MACE, and a 7-fold hazard was observed per 10% LGE extent after adjustments for patient age, sex, and LVEF (adjusted HR: 7.61; p < 0.0001). LGE quantitation by 2-SD and FWHM both demonstrated robust prognostic association, with the highest MACE rate observed in patients with LGE involving >6.1% of LV myocardium. LGE extent may provide further risk stratification in patients with NIDC with a current indication for ICD implantation for the primary prevention of SCD. Strategic guidance on ICD therapy by cardiac magnetic resonance in patients with NIDC warrants further study.
登录
查看更多内容
DOI:
10.1161/circimaging.108.842096
发表时间:
2010-11
期刊:
Circulation. Cardiovascular imaging
影响因子:
--
作者:
Broberg CS;Chugh SS;Conklin C;Sahn DJ;Jerosch-Herold M
通讯作者:
Jerosch-Herold M
影响因子:
24
作者:
Amado, LC;Gerber, BL;Lima, JAC
通讯作者:
Lima, JAC
影响因子:
24
作者:
Assomull, Ravi G.;Prasad, Sanjay K.;Pennell, Dudley J.
通讯作者:
Pennell, Dudley J.
DOI:
10.1016/s0735-1097(86)80476-4
发表时间:
1986-03-01
影响因子:
24
作者:
HAMMOND, IW;DEVEREUX, RB;LARAGH, JH
通讯作者:
LARAGH, JH
影响因子:
24
作者:
Bogun, Frank M.;Desjardins, Benoit;Good, Eric;Gupta, Sanjaya;Crawford, Thomas;Oral, Hakan;Ebinger, Matthew;Pelosi, Frank;Chugh, Aman;Jongnarangsin, Krit;Morady, Fred
通讯作者:
Morady, Fred